CY1106807T1 - Σταθερη συνθεση που περιεχει φουμαγιλλινη - Google Patents

Σταθερη συνθεση που περιεχει φουμαγιλλινη

Info

Publication number
CY1106807T1
CY1106807T1 CY20071101062T CY071101062T CY1106807T1 CY 1106807 T1 CY1106807 T1 CY 1106807T1 CY 20071101062 T CY20071101062 T CY 20071101062T CY 071101062 T CY071101062 T CY 071101062T CY 1106807 T1 CY1106807 T1 CY 1106807T1
Authority
CY
Cyprus
Prior art keywords
composition containing
stable composition
fumagillin
containing fumagillin
stable
Prior art date
Application number
CY20071101062T
Other languages
English (en)
Inventor
Bernard Abramovici
Jean-Luc Dubois
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9902401A external-priority patent/FR2790200B3/fr
Priority claimed from FR9909702A external-priority patent/FR2796842B3/fr
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of CY1106807T1 publication Critical patent/CY1106807T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Περιγράφεται μια σταθερή σύνθεση της φουμαγιλλίνης για τη χορήγηση από το στόμα ή από τον πρωκτό, η οποία περιέχει δικαπρατική / δικαπρυλατική προπυλενεγλυκόλη.
CY20071101062T 1999-02-26 2007-08-08 Σταθερη συνθεση που περιεχει φουμαγιλλινη CY1106807T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9902401A FR2790200B3 (fr) 1999-02-26 1999-02-26 Formulation stable contenant de la fumagilline
FR9909702A FR2796842B3 (fr) 1999-07-27 1999-07-27 Formulation stable contenant de la fumagilline
PCT/FR2000/000424 WO2000050084A1 (fr) 1999-02-26 2000-02-21 Formulation stable contenant de la fumagilline

Publications (1)

Publication Number Publication Date
CY1106807T1 true CY1106807T1 (el) 2012-05-23

Family

ID=26234836

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101062T CY1106807T1 (el) 1999-02-26 2007-08-08 Σταθερη συνθεση που περιεχει φουμαγιλλινη

Country Status (12)

Country Link
US (1) US6528539B1 (el)
EP (1) EP1156829B1 (el)
JP (1) JP2002537358A (el)
AT (1) ATE361757T1 (el)
AU (1) AU2811400A (el)
CY (1) CY1106807T1 (el)
DE (1) DE60034770T2 (el)
DK (1) DK1156829T3 (el)
ES (1) ES2286998T3 (el)
HU (1) HU228857B1 (el)
PT (1) PT1156829E (el)
WO (1) WO2000050084A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100598871B1 (ko) * 2001-09-10 2006-07-12 에프. 호프만-라 로슈 아게 유성 요변성 제제
CA2820023A1 (en) * 2002-09-26 2007-12-19 Vita-Herb Nutriceuticals, Inc. Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
NZ585547A (en) * 2007-11-28 2012-12-21 Mersana Therapeutics Inc Biocompatible biodegradable fumagillin analog conjugates
JP5873375B2 (ja) * 2012-04-03 2016-03-01 中日本カプセル 株式会社 ソフトカプセル及びソフトカプセルの製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918103A (en) * 1988-07-25 1990-04-17 Formulations Development Labs Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
DE69311278T2 (de) 1992-12-16 1997-10-30 Takeda Chemical Industries Ltd Stabile pharmazeutische Zubereitung mit Fumagillolderivaten
CN1072485C (zh) * 1995-03-27 2001-10-10 萨诺费合成实验室 夫马菌醇及其衍生物用于制备抗肠道感染药物的用途
JPH1081621A (ja) * 1996-04-01 1998-03-31 Takeda Chem Ind Ltd 経口投与用医薬組成物
EP0799616A1 (en) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Oral composition comprising a fumagillol derivative
US20010025046A1 (en) * 1999-06-24 2001-09-27 Rong(Ron) Liu Self-emulsifying systems containing anticancer medicament
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions

Also Published As

Publication number Publication date
HUP0202151A3 (en) 2005-02-28
HUP0202151A2 (en) 2002-10-28
DK1156829T3 (da) 2007-09-10
ES2286998T3 (es) 2007-12-16
AU2811400A (en) 2000-09-14
DE60034770T2 (de) 2008-04-30
PT1156829E (pt) 2007-08-17
ATE361757T1 (de) 2007-06-15
HU228857B1 (en) 2013-06-28
US6528539B1 (en) 2003-03-04
EP1156829B1 (fr) 2007-05-09
DE60034770D1 (de) 2007-06-21
EP1156829A1 (fr) 2001-11-28
WO2000050084A1 (fr) 2000-08-31
JP2002537358A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
CY1106807T1 (el) Σταθερη συνθεση που περιεχει φουμαγιλλινη
CY1111071T1 (el) Φαρμακευτικες ενωσεις που περιεχουν τα παραγωγα αζετιδινης, τα νεα παραγωγα αζετιδινης και η παρασκευη τους
CY1107331T1 (el) Στερεες τυποποιησεις κετιριζινης ταχειας διαλυσης
CY1105387T1 (el) Υποκατεστημενα παραγωγα 2-διαλκυλαμινοαλκυλοδιφαινθλιου
ES2135347B1 (es) Hidroxifeniltriazinas.
CY1105043T1 (el) Υδατοδιαλυτa προφaρμακα παρεμποδισμeνων φαινολων
ATE322485T1 (de) Propan-1,3-dion-derivate
HRP20000494B1 (en) Pharmaceutically active morpholinol
EE04799B1 (et) Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
DK1566166T3 (da) Base til oral sammensætning og oral sammensætning
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
BR9900443A (pt) Esteres de ácido aril acrìlico.
DE3681400D1 (de) Mittel zur mundhygiene.
NO20014035L (no) System for oral administrasjon av medikament
CY1107506T1 (el) Μεθοδος για σταθεροποιηση ενωσεων βενζιμιδαζολης
TR200003108T2 (tr) İlaç kompozisyonları
HN2002000300A (es) Nuevos derivados de piperazina
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
CY1106633T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c
ATE385799T1 (de) Zusammensetzung einer natriumkanal-blockierenden verbindung
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
CO5560531A2 (es) Producto antitranspirante con dibencilideno sorbitol y elastomero en dimeticona
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
NO20060509L (no) Halvfaste systemer inneholdende azetidinderivater
DE60005517D1 (de) Kaliumkanal-blockierende mittel